Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Modified Process Preflucel vs Current Process and Fluzone in Adults
NCT01773928Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Jan 2013
- Primary completion
- Apr 2013
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated influenza vaccine (vero cell-derived) in influenza, sponsored by Resilience Government Services. Started Jan 2013; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01773928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773928.